IPV
IPV is a pharmaceutical drug with 16 clinical trials. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
10 of 13 finished
23.1%
3 ended early
0
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants
Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV
Immunogenicity of Intramuscular and Intradermal IPV
Clinical Trials (16)
A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants
Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV
Immunogenicity of Intramuscular and Intradermal IPV
Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients
Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh
Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV
Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine
A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine
Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh
Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules
Polio End-game Strategies - Poliovirus Type 2 Challenge Study
Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine
Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16